Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Erbitux

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Erbitux was produced by Merck & Co. and Bristol-Myers Squibb.

Medicine Gets Personal

Merck Serono (MS) markets Erbitux, a personalised medicine (PM) that is used to treat patients with advanced bowel cancer identified using a predictive biomarker test, KRAS. ... For the marker test to be offered to people, whether or not they ended up

Cost deters NICE from Sanofi's bowel cancer drug Zaltrap

Cost deters NICE from Sanofi's bowel cancer drug Zaltrap However, there is also a growing list of drugs rejected for use in colorectal by NICE, including Roche's Avastin (bevacizumab), Merck KGaA's Erbitux (cetuximab) and Amgen's Vectibix (panitumumab),

Mirna hires former Pfizer director as CMO

Mirna hires former Pfizer director as CMO Prior to this, he was director of clinical oncology at Bristol-Myers Squibb where he worked on the clinical development of Erbitux (cetuximab), which is approved for colorectal cancer and head

Merck KGaA to meet 2014 financial targets one year early

Merck KGaA to meet 2014 financial targets one year early Cancer therapy Erbitux (cetuximab) also had a solid quarter – up 6.6 per cent to 222m – thanks to approval for head and neck cancer in Japan and gains in emerging markets,

Amgen forms joint venture in China to boost Vectibix

Amgen forms joint venture in China to boost Vectibix therapies such as Eli Lilly/Merck Serono's Erbitux (cetuximab) and Roche's Avastin (bevacizumab). . ... Erbitux as a single agent for the treatment of metastatic CRC patients with wild-type KRAS tumours.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....